TransCon TLR7/8
ascendis pharmaceuticals
['advance', 'ascend,(-ascended)', 'ascendis', '$asnd']
$asnd dose escalation data from transcendit-101, ascendis pharma s phase 1/2 trial of transcon tlr7/8 agonist in patients with advanced solid tumors, presented at sitc 2022 